The Role of SV40 in Malignant Mesothelioma and Other Human Malignancies

August 22, 2006 | Comments Off on The Role of SV40 in Malignant Mesothelioma and Other Human Malignancies

Inhalation Toxicology. 2006 Nov;18(12):995-1000. [Link] Pershouse MA, Heivly S, Girtsman T. Center for Environmental Health Sciences, Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, Montana, USA. Abstract SV40…

Animal models of malignant mesothelioma

August 22, 2006 | Comments Off on Animal models of malignant mesothelioma

Inhalation Toxicology. 2006 Nov;18(12):1001-4. [Link] Kane AB. Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, USA. Abstract Animal models of diffuse malignant mesothelioma have historically been used…

Tumor suppressor gene alterations in patients with malignant mesothelioma due to environmental asbestos exposure in Turkey

August 22, 2006 | Comments Off on Tumor suppressor gene alterations in patients with malignant mesothelioma due to environmental asbestos exposure in Turkey

Journal of Carcinogenesis. 2006 Aug 22;5:23. [Link] Esra Tug1, Tuncer Tug2 , Halit Elyas3 , Mehmet Coskunsel4 and Salih Emri5 1Department of Medical Genetics, Abant Izzet Baysal University, Izzet Baysal…

Diagnostic value of thoracoscopic pleural biopsy for pleurisy under local anaesthesia

August 21, 2006 | Comments Off on Diagnostic value of thoracoscopic pleural biopsy for pleurisy under local anaesthesia

ANZ Journal of Surgery. 2006 Aug;76(8):722-4. [Link] Motoki Sakuraba*, Kimihiko Masuda†, Akira Hebisawa‡, Yuzo Sagara*, and Hikotaro Komatsu* Departments of *Thoracic Surgery, †Respiratory Medicine, and ‡Division of Pathology, National Hospital…

Change in Gene Expression Profile Induced by a-Melanocyte Stimulating Hormone in a Malignant Mesothelioma Cell Line

August 18, 2006 | Comments Off on Change in Gene Expression Profile Induced by a-Melanocyte Stimulating Hormone in a Malignant Mesothelioma Cell Line

Cell Mol Biol (Noisy-le-grand). 2006 May 30;52(2):69-74. [Link] Colombo G, Sordi A, Turcatti F, Carlin A, Rossi C, Lonati C, Santambrogio L, Gatti S, Catania A. Fondazione IRCCS Ospedale Maggiore…

Factors affecting the mesothelioma detection rate within national and international epidemiological studies: insights from Scottish linked cancer registry-mortality data

August 16, 2006 | Comments Off on Factors affecting the mesothelioma detection rate within national and international epidemiological studies: insights from Scottish linked cancer registry-mortality data

Br J Cancer. 2006 Aug 8; [Epub ahead of print] [Link] Camidge DR, Stockton DL, Bain M. Edinburgh Cancer Centre, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK. Abstract…

In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility

August 15, 2006 | Comments Off on In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility

Environmental Science and Technology. 2006 Jul 15;40(14):4374-81. [Link] Brunner TJ, Wick P, Manser P, Spohn P, Grass RN, Limbach LK, Bruinink A, Stark WJ. Institute for Chemical and Bioengineering, Department…

Podoplanin: a novel diagnostic immunohistochemical marker

August 11, 2006 | Comments Off on Podoplanin: a novel diagnostic immunohistochemical marker

Advances in Anatomic Pathology. 2006 Mar;13(2):83-8. [Link] Ordonez NG. University of Texas, Anderson Cancer Center, Houston, TX 77030, USA. nordonez@mdanderson.org Abstract Podoplanin is a transmembrane mucoprotein recognized by the recently…

Schedule-dependent interactions between pemetrexed and cisplatin in human carcinoma cell lines in vitro

August 11, 2006 | Comments Off on Schedule-dependent interactions between pemetrexed and cisplatin in human carcinoma cell lines in vitro

Oncology Research. 2006;16(2):85-95. [Link] Kano Y, Akutsu M, Tsunoda S, Izumi T, Kobayashi H, Inoue K, Mori K, Fujii H, Mano H, Odgerel T, Furukawa Y. Division of Hematology, Tochigi…

Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma

August 9, 2006 | Comments Off on Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma

Lung Cancer. 2006 Aug 4; [Epub ahead of print] [Link] Fischer JR, Ohnmacht U, Rieger N, Zemaitis M, Stoffregen C, Kostrzewa M, Buchholz E, Manegold C, Lahm H. Department of…

Categories